MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

36.92 -1.39 (-3.63%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TG Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
Despite its growth, NASDAQ:TGTX remains within the realm of affordability. ↗
While growth is established for TG THERAPEUTICS INC (NASDAQ:TGTX), the stock's valuation remains reasonable. 
Via Chartmill
News headline image
NASDAQ:TGTX—Positioned as a High-Growth Stock, Ready for a Potential Breakout. ↗
TG THERAPEUTICS INC (NASDAQ:TGTX)—Positioned as a High-Growth Stock, Ready for a Potential Breakout. 
Via Chartmill
News headline image
What's Going On With ADMA Biologics Stock Monday? ↗
ADMA Biologics shares are moving higher after it was announced that the company will join the S&P SmallCap 600. 
Via Benzinga
Topics Stocks
News headline image
Why NASDAQ:TGTX is Poised for High Growth. ↗
Exploring TG THERAPEUTICS INC (NASDAQ:TGTX)'s growth characteristics. 
Via Chartmill
News headline image
In the world of growth stocks, NASDAQ:TGTX shines as a value proposition. ↗
NASDAQ:TGTX, a growth stock which is not overvalued. 
Via Chartmill
News headline image
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Decoding TG Therapeutics's Options Activity: What's the Big Picture? ↗
 
Via Benzinga
News headline image
IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter ↗
The company reported a surprise profit in the second quarter, vs. expectations for losses. 
Via Investor's Business Daily
News headline image
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Why the growth investor may take a look at NASDAQ:TGTX. ↗
Is TG THERAPEUTICS INC (NASDAQ:TGTX) suited for growth investing? 
Via Chartmill
News headline image
A Closer Look at TG Therapeutics's Options Market Dynamics ↗
 
Via Benzinga
News headline image
NASDAQ:TGTX: a strong growth stock preparing for the next leg up?. ↗
TG THERAPEUTICS INC (NASDAQ:TGTX) qualifies as a high growth stock and is consolidating. 
Via Chartmill
News headline image
Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review ↗
After Monday's panicked global sell-off, markets have calmed down. 
Via Investor's Business Daily
News headline image
NASDAQ:TGTX is showing decent growth, but is still valued reasonably. ↗
NASDAQ:TGTX stands out as a growth opportunity that won't break the bank. 
Via Chartmill
News headline image
S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimates ↗
 
Via Benzinga
Topics Earnings Stocks
News headline image
Crude Oil Moves Higher; Yum! Brands Posts Upbeat Earnings ↗
 
Via Benzinga
News headline image
TGTX Stock Earnings: TG Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗
TGTX stock results show that TG Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
$1000 Invested In TG Therapeutics 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
(TGTX) - Analyzing TG Therapeutics's Short Interest ↗
 
Via Benzinga
News headline image
Peering Into TG Therapeutics's Recent Short Interest ↗
 
Via Benzinga
News headline image
TG Therapeutics Stock Jumps As Surprise Profit Smashes Views By 157% ↗
The company unexpectedly reported profit in the second quarter, handily beating views for a per-share loss. 
Via Investor's Business Daily
News headline image
In the world of growth stocks, NASDAQ:TGTX shines as a value proposition. ↗
Looking for growth without the hefty price tag? Consider TG THERAPEUTICS INC (NASDAQ:TGTX). 
Via Chartmill
News headline image
"Rule Breaker Investing" Market Cap Game Show: Bill Mann vs. Bill Barker ↗
Our first-ever twin bill. 
Via The Motley Fool
News headline image
Nasdaq 100 Overbought? Here’s What History Says About The Current Rally ↗
Find out the historical patterns traders can look for to anticipate the next move in the Nasdaq 100. 
Via Talk Markets
News headline image
The Most Shorted Stocks in June: Hold, Short, or Squeeze?
Given the proper catalyst, the short interest in these stocks may lead to a short squeeze. All the market needs is a push and it may come at any time. 
Via MarketBeat
News headline image
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
EQNX::TICKER_START (NASDAQ:TLSA),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:BIIB),(NASDAQ:TGTX) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Why TG Therapeutics Stock Was Rocketing Higher This Week ↗
The company raised guidance for sales of its drug for relapsing multiple sclerosis. 
Via The Motley Fool
News headline image
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
From FN Media Group LLC
Via GlobeNewswire
News headline image
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story